AIDS CARE - Psychological and Socio-Medical Aspects of AIDS/HIV, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital interdisciplinary platform for researchers, clinicians, and policymakers exploring the complex psychological and socio-medical dimensions of HIV/AIDS. With an ISSN of 0954-0121 and an E-ISSN of 1360-0451, this esteemed journal has been disseminating significant research since 1989 and continues to uphold a commendable reputation in the field, achieving a Q2 ranking in esteemed categories such as Health (Social Science), Public Health, and Social Psychology as per 2023 metrics. Its commitment to enhancing understanding of HIV/AIDS through quantitative and qualitative research makes it essential for stakeholders engaged in health strategies and mental health interventions. While currently not offering open access, the journal provides access to a wealth of authoritative articles that contribute meaningfully to the ongoing discourse surrounding HIV/AIDS and its socio-psychological ramifications. Researchers and students aiming to deepen their knowledge and intervention strategies will find this journal an invaluable resource.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier academic resource in the field of infectious diseases and microbiology. With its ISSN 0891-5520 and E-ISSN 1557-9824, this esteemed journal has been at the forefront of disseminating critical research findings and clinical advancements since its inception in 1987. Known for its high impact, the journal ranks in the Q1 category for both Infectious Diseases and Medical Microbiology as of 2023, which underscores its significant contribution to advancing knowledge and practice in these vital areas. Researchers, practitioners, and students alike rely on its comprehensive yet concise reviews and original articles, ensuring they stay abreast of emerging trends and therapeutics in infectious disease management. Although it does not offer open access, the journal remains pivotal in enriching scholarly dialogue and influencing clinical practices in the United States and beyond. Explore this vital publication and join a community dedicated to excellence in infectious disease research.

JAIDS - Journal of Acquired Immune Deficiency Syndromes, is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the dynamics of HIV/AIDS and its broader implications in the fields of infectious diseases and pharmacology. With an esteemed impact factor that places it in the prestigious Q1 category for both Infectious Diseases and Pharmacology (medical) as of 2023, this journal aims to provide a platform for groundbreaking research, clinical findings, and innovative therapies relevant to the management and prevention of HIV/AIDS. The journal's rigorous editorial standards and commitment to advancing knowledge make it an essential resource for researchers, healthcare professionals, and students invested in the global response to AIDS. Although the journal does not currently offer open access options, it remains instrumental in disseminating high-quality research that shapes clinical practices and policy developments in the field.

Journal of Primary Health Care, published by CSIRO PUBLISHING, is a premier open-access journal dedicated to advancing the field of primary health care since its inception in 2009. With an E-ISSN of 1172-6156, the journal serves as a vital platform for disseminating innovative research and practices that improve health outcomes across diverse populations. Featuring a robust H-index and notable rankings—including Q2 in Family Practice and Q3 in both Medicine (miscellaneous) and Public Health—this journal holds a significant position within the academic community, offering valuable insights to researchers, practitioners, and students alike. By providing open-access options, the Journal of Primary Health Care ensures that its findings are accessible to a global audience, promoting collaboration and knowledge sharing. As we look toward 2024, we invite contributors to be part of this dynamic conversation, addressing the critical issues in primary health care delivery and policy.

AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.

The Journal of the International AIDS Society, published by John Wiley & Sons Ltd, stands as a premier platform for advancing knowledge in the realms of infectious diseases and public health, boasting a strong Q1 ranking in both categories as of 2023. With its open-access format established since 2004, the journal ensures that groundbreaking research on HIV/AIDS and related issues is widely disseminated and easily accessible to a global audience. This commitment to accessibility significantly enhances its impact factor, making it a vital resource for researchers, practitioners, and students alike who are dedicated to improving health outcomes and understanding the complexities of the epidemic. Covering a diverse range of topics from prevention strategies to health policy, the journal supports its readers in staying at the forefront of public health discourse. With its base in the United States and an impressive Scopus ranking placing it within the top tiers of medical publications, the Journal of the International AIDS Society continues to foster collaboration and innovation in the fight against HIV/AIDS.

AIDS REVIEWS, published by Permanyer Publishing, is a distinguished academic journal dedicated to providing comprehensive insights into the field of AIDS research. Since its inception in 2000, the journal has served as a vital platform for disseminating knowledge on various aspects of HIV/AIDS, including prevention, treatment advancements, and socio-medical implications. With a commendable Q3 ranking in both Infectious Diseases and Medicine (miscellaneous), as well as Pharmacology (medical) in 2023, the journal has made significant strides in the academic community, covering relevant topics and emerging trends up to 2024. Although not open access, AIDS REVIEWS continues to attract contributions from leading researchers and professionals, fostering a collaborative environment aimed at improving health outcomes related to AIDS. Located in Barcelona, Spain, this journal is an essential resource for anyone dedicated to advancing their understanding of this global health challenge.

AJAR - African Journal of AIDS Research, an esteemed publication by Taylor & Francis Ltd, stands at the forefront of research in the field of HIV/AIDS, with a specific focus on the African continent. Established in 2003 and publishing continuously through 2024, this journal serves as a crucial platform for disseminating innovative research findings aimed at addressing the challenges of HIV/AIDS. With its ISSN 1608-5906 and E-ISSN 1727-9445, AJAR is indexed in prominent databases and holds a respectable Q3 rating in major categories such as Infectious Diseases, Medicine, Public Health, and Virology as of 2023. This positions the journal as a relevant resource for scholars and medical professionals looking to stay informed on the latest developments and strategies in AIDS research. Although it is not currently an open-access journal, AJAR provides readers with valuable insights that are essential for advancing public health initiatives and infectious disease research across Africa and beyond. The journal's commitment to high-quality peer-reviewed research underscores its importance within its field, making it a vital resource for researchers, students, and policymakers alike.

AIDS Research and Therapy is a prestigious peer-reviewed journal dedicated to disseminating cutting-edge research in the fields of AIDS and HIV therapy. Published by BMC, this Open Access journal has been freely available since its inception in 2004, facilitating global access to vital research findings. Based in the United Kingdom, the journal covers a diverse range of topics including molecular medicine, pharmacology, and virology, making it a crucial resource for researchers and clinicians alike. Recognized for its strong impact within the scientific community, it holds a Q2 quartile ranking in multiple categories as of 2023, including Molecular Medicine and Pharmacology. With an aim to enhance understanding and improve clinical outcomes for those affected by HIV/AIDS, AIDS Research and Therapy serves as an essential platform for the exchange of innovative ideas and practices that can inform future therapies and interventions. Researchers, professionals, and students seeking high-quality, peer-reviewed content will find this journal invaluable in advancing their knowledge and efforts in combating the HIV/AIDS epidemic.

Current HIV Research is a pivotal journal dedicated to the latest advancements in the field of HIV research, published by Bentham Science Publishers Ltd. With a commitment to disseminating high-quality research, this journal serves as a critical resource for researchers, healthcare professionals, and students interested in infectious diseases and virology. The journal has an ISSN of 1570-162X and an E-ISSN of 1873-4251, reflecting its commitment to contemporary digital scholarship. Given its publication history spanning from 2003 to 2024, the journal has continually provided insights and peer-reviewed articles that foster knowledge and innovation in HIV research. Although it currently holds a Q3 ranking in Infectious Diseases and a Q4 ranking in Virology, these rankings underscore its importance as an emerging platform for critical research dialogue. Despite not being an Open Access journal, 'Current HIV Research' ensures that cutting-edge studies reach relevant practitioners and contribute to ongoing discourse in the medical community. By fostering an informed approach to HIV and its implications, this journal is an invaluable asset to those committed to advancing their expertise in this crucial area of health science.